Overview

Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The three study drugs (Thalidomide, Taxol, and Estramustine) used in this study are all chemotherapy drugs used in shrinking the cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborators:
Celgene
Celgene Corporation
Treatments:
Albumin-Bound Paclitaxel
Androgens
Estramustine
Paclitaxel
Thalidomide